In recent trading session, Alto Neuroscience Inc (NYSE:ANRO) saw 0.4 million shares changing hands at last check today with its beta currently measuring 1.97. Company’s recent per share price level of $2.44 trading at -$0.13 or -5.06% at last check today assigns it a market valuation of $66.06M. That most recent trading price of ANRO’s stock is at a discount of -619.26% from its 52-week high price of $17.55 and is indicating a premium of 34.43% from its 52-week low price of $1.60. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.27 million shares which gives us an average trading volume of 255.36K if we extend that period to 3-months.
For Alto Neuroscience Inc (ANRO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.38. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Alto Neuroscience Inc (NYSE:ANRO) trade information
Upright in the red during last session for losing -5.06%, in the last five days ANRO remained trading in the green while hitting it’s week-highest on Wednesday, 06/25/25 when the stock touched $2.44 price level, adding 7.92% to its value on the day. Alto Neuroscience Inc’s shares saw a change of -76.67% in year-to-date performance and have moved 7.49% in past 5-day. Alto Neuroscience Inc (NYSE:ANRO) showed a performance of -14.98% in past 30-days. Number of shares sold short was 2.79 million shares which calculate 11.63 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 10 to the stock, which implies a rise of 75.6% to its recent value today. Analysts have been projecting 10 as a low price target for the stock while placing it at a high target of 10. It follows that stock’s current price would drop -309.84% in reaching the projected high whereas dropping to the targeted low would mean a loss of -309.84% for stock’s current value.
In 2025, company’s earnings growth rate is likely to be around 1.07% while estimates for its earnings growth in next 5 years are of -5.25%.
Alto Neuroscience Inc (NYSE:ANRO)’s Major holders
Insiders are in possession of 7.48% of company’s total shares while institution are holding 77.52 percent of that, with stock having share float percentage of 83.79%. Investors also watch the number of corporate investors in a company very closely, which is 77.52% institutions for Alto Neuroscience Inc that are currently holding shares of the company. ALPHA WAVE GLOBAL, LP is the top institutional holder at ANRO for having 3.71 million shares of worth $39.64 million. And as of 2024-06-30, it was holding 13.7576 of the company’s outstanding shares.
The second largest institutional holder is FMR LLC, which was holding about 2.33 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.6492 of outstanding shares, having a total worth of $24.92 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 721.24 shares of worth $1.76 million or 2.66% of the total outstanding shares. The later fund manager was in possession of 503.61 shares on Apr 30, 2025 , making its stake of worth around $1.23 million in the company or a holder of 1.86% of company’s stock.
